These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Increase of NAD(P)H:quinone reductase by dietary antioxidants: possible role in protection against carcinogenesis and toxicity. Benson AM; Hunkeler MJ; Talalay P Proc Natl Acad Sci U S A; 1980 Sep; 77(9):5216-20. PubMed ID: 6933553 [TBL] [Abstract][Full Text] [Related]
45. Fecalase: a model for activation of dietary glycosides to mutagens by intestinal flora. Tamura G; Gold C; Ferro-Luzzi A; Ames BN Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4961-5. PubMed ID: 6933540 [TBL] [Abstract][Full Text] [Related]
46. Toxicological profile of praziquantel, a new drug against cestode and schistosome infections, as compared to some other schistosomicides. Frohberg H; Schulze Schencking M Arzneimittelforschung; 1981; 31(3a):555-65. PubMed ID: 7195246 [TBL] [Abstract][Full Text] [Related]
47. Dissociation of mutagenic and other toxic properties from schistosomicides. Bueding E J Toxicol Environ Health; 1975 Nov; 1(2):329-34. PubMed ID: 1206775 [TBL] [Abstract][Full Text] [Related]
48. Mutagenic activation of an antischistosomal drug by enteric Streptococcus sps in vitro and in vivo. Molineaux CJ; Batzinger RP; Schmidt W; Bueding E Teratog Carcinog Mutagen; 1980; 1(2):129-39. PubMed ID: 6119805 [TBL] [Abstract][Full Text] [Related]
49. Protection from mutagenic effects of antischistosomal and other drugs. Bueding E; Batzinger RP; Cha YN; Talalay P; Molineaux CJ Pharmacol Rev; 1978 Dec; 30(4):547-54. PubMed ID: 392546 [No Abstract] [Full Text] [Related]
50. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC publication No. 18. Review of the genotoxicity and carcinogenicity of antischistosomal drugs; is there a case for a study of mutation epidemiology? Report of a task group on mutagenic antischistosomals. Kramers PG; Gentile JM; Gryseels BJ; Jordan P; Katz N; Mott KE; Mulvihill JJ; Seed JL; Frohberg H Mutat Res; 1991 Jan; 257(1):49-89. PubMed ID: 1987457 [TBL] [Abstract][Full Text] [Related]
51. The pharmacology and biochemistry of N-oxides. Bickel MH Pharmacol Rev; 1969 Dec; 21(4):325-55. PubMed ID: 4902323 [No Abstract] [Full Text] [Related]
52. [Toxicity, carcinogenic, mutagenic, teratogenic action of dichlorvos]. Lafontaine A; Aerts J; Jacques P Arch Belg Med Soc; 1981 Mar; 39(3):159-74. PubMed ID: 7030204 [No Abstract] [Full Text] [Related]
53. Flavonoids and alkenylbenzenes: mechanisms of mutagenic action and carcinogenic risk. Rietjens IM; Boersma MG; van der Woude H; Jeurissen SM; Schutte ME; Alink GM Mutat Res; 2005 Jul; 574(1-2):124-38. PubMed ID: 15914212 [TBL] [Abstract][Full Text] [Related]